Patient Financing Is Becoming Standard, Not Optional.

If you're still treating patient financing as the thing you mention after someone flinches at the treatment plan, you're running a 2015 playbook in a 2026 market. Financing has moved from a closing tool to a table-stakes feature of the practice, the same way online scheduling did. Patients now shop for it before they ever sit in your chair, and the data says the ones who can't find it just don't get the dentistry.

Here's the short version: cost is the single biggest barrier in dentistry, bigger than in any other part of healthcare. A fifth of working-age adults have no dental benefits at all. Out-of-pocket spending is growing faster than insurance spending. And a majority of patients say financing availability factors into which provider they pick. Put those four facts together and the conclusion is uncomfortable but simple. If you don't have a financing program that approves most applicants, you are quietly outsourcing a large chunk of your production to the practice down the street that does.

Dentistry Has the Worst Cost Barrier in Healthcare

This isn't a soft claim. In 2023, roughly 13% of the U.S. population did not get needed dental care because of cost, according to the ADA Health Policy Institute's national trends report. That's the highest cost-barrier rate of any health service they track. Medical care, prescription drugs, and eyeglasses all sit around 5%. Mental health care is around 4%.

Read that again, because it reframes the whole conversation. Dentistry's cost barrier is roughly two and a half times the rate of medical care. People who will find a way to fill a prescription will walk away from a crown. That's not a patient education problem and it's not a "they don't value their health" problem. It's a payment structure problem, and it's yours to solve inside your own four walls because nobody is coming to fix it at the policy level.

One in Five Working-Age Adults Pays Entirely Out of Pocket

The benefits picture explains a lot of that gap. Among working-age adults aged 19 to 64, ADA HPI data shows 63% have private dental benefits, 16% have public benefits, and 21% have no dental benefits whatsoever.

That 21% is the number to stare at. If you have 1,800 active patients and your panel mirrors the national mix, roughly 378 of them are paying cash for everything you do. For those patients, there is no maximum plan benefit to bump against and no downgrade clause to argue about. There's only the number you quote and whether they can absorb it this month.

And the uninsured group isn't the only cash-pay population. Your insured patients hit their annual maximum, which in most plans hasn't meaningfully moved in decades. The moment a patient blows through $1,500 of benefit in March, they are functionally uninsured for the rest of the year. Every practice has a stack of treatment plans that died in April through December for exactly this reason.

Out-of-Pocket Money Is Growing Faster Than Insurance Money

National dental expenditure hit $189 billion in 2024, and the mix is shifting. Out-of-pocket dental spending grew 3.3% year over year from 2023 to 2024, outpacing the 2.3% growth in private dental insurance spending, per ADA HPI's national dental expenditures data.

Correction on that figure: the reported national dental expenditure is $89 billion in 2024 per the same source. The directional point holds either way. Patient dollars are the faster-growing share of the market, and insurer dollars are the slower one. If your revenue engine is built primarily on PPO reimbursement, you've indexed your practice to the slower-growing line. The faster-growing line is patient wallets, and patient wallets require a payment mechanism.

Patients Shop for Financing Before They Shop for You

The behavioral data from CareCredit's research on how cost impacts the patient journey is blunt. 52% of patients say they struggle to pay out-of-pocket health and wellness expenses. 76% say they'd seek more services if payment options were available. And 59% rate the availability of financing options as extremely or very important when choosing a provider.

That last number is the one that turns financing from a sales tool into a marketing asset. Almost six in ten patients are factoring payment options into provider selection. That decision happens before the exam, before the treatment plan, before your case presentation skills ever come into play. If your website and your phone script don't mention financing, you're losing patients at a stage you can't even measure.

The 76% figure deserves attention too. Three quarters of patients say they'd pursue more care if payment options existed. That's not a claim that they'd accept every plan you present. It's a claim that the pool of treatment they consider viable expands when the payment question has an answer. Your diagnosis doesn't change. The set of patients who can act on it does.

The Approval Rate Is the Whole Ballgame

Here's where most practices go wrong. They sign up for one financing partner, watch half their patients get declined, conclude that "financing doesn't work for our demographic," and quietly stop offering it.

The problem isn't the concept. It's the approval rate. Sunbit reports an 87% approval rate for dental patients applying for financing, compared to roughly 40% typical approval rates from traditional lenders for prime-credit patients. That's not a rounding difference. That's the difference between a program your team trusts and a program your team stops mentioning because they're tired of watching patients get embarrassed at the front desk.

Approval rate drives everything downstream. A team that watches 87 out of 100 applicants get approved will offer financing to every patient without hesitation. A team that watches 40 out of 100 get approved will start pre-judging who "looks like" they'd qualify, which is both terrible practice management and a guaranteed way to miss cases. Your front desk's willingness to make the offer is a direct function of how often the offer works.

Operator Math

Let's put real dollars on it. Take a practice where 12 patients per month leave without scheduling because of cost. That's conservative for a single-doctor general practice with a full hygiene schedule. Average case value on those plans is $2,400, which is roughly a crown plus buildup or a quadrant of perio therapy with follow-up.

If none of those 12 get financed, you're walking away from $28,800 in monthly production. Annualized, that's $345,600 in diagnosed treatment that never happens.

Now run it with a high-approval financing program at the 87% rate Sunbit reports. Of those 12 patients, 10.44 get approved. At $2,400 per case, that's $25,056 in monthly production you captured instead of lost.

Compare that to a traditional lender at a 40% approval rate. Only 4.8 of your 12 patients get approved. That's $11,520 per month. The gap between the two programs is $13,536 every single month. Over a year, choosing the higher-approval partner is worth $162,432 in production.

Financing isn't free, so subtract the cost. Say your merchant discount runs 8% of the financed amount. On $25,056 in monthly financed production, that's $2,004.48 in fees. Annualized, the fee load is $24,053.76.

Gross annual production from the financed cases is $300,672. Net of financing fees, you keep $276,618.24. That's $276,618.24 of production that, without the program, simply doesn't exist. You're not paying 8% on revenue you already had. You're paying 8% on revenue that was otherwise a zero.

One more comparison that should end the fee objection. On a $2,400 case, an 8% financing fee costs you $192. A PPO contract that writes off 25% of your fee on that same case costs you $600. You've been accepting the larger discount for years without blinking. The financing fee is less than a third of it, and it comes with a patient who chose you partly because you offered the option.

How to Run It Without Wrecking Your Front Desk

Three things separate practices where financing works from practices where it sits unused in a drawer.

• Offer it to everyone, every time. The moment your team starts deciding who looks like a candidate, you've introduced bias and lost cases. Build it into the script for every plan over a threshold you set, say $800. No exceptions, no judgment calls.
• Lead with the monthly number, not the total. Patients don't reject $2,400. They reject $2,400 due today. Present the plan total, then immediately present the monthly figure. The treatment coordinator who says "that's $2,400, and we have options that put it around $100 a month" gets a different answer than the one who stops at $2,400.
• Put it on your website and in your phone script. With 59% of patients weighing financing availability when picking a provider, per CareCredit's data, keeping it a secret until case presentation means you never meet the patients who filtered you out.

Also: track your approval rate monthly. If your partner is approving well under the rates the market is advertising, that's a vendor problem, not a patient problem. Practices carrying two options, a primary with high approval and a secondary for the declines, tend to catch most of the gap.

The Takeaway

Audit your last 90 days of unscheduled treatment and count how many plans died on cost instead of clinical disagreement. Then check your current financing partner's actual approval rate against the 87% the market is advertising, and if yours is closer to 40%, replace it or add a second option behind it. Build financing into the script for every plan above your threshold so the offer stops being a judgment call. Then put it on your website and in your phone greeting, because a majority of patients are deciding on payment options before they ever call you.

If this article lands, the next question is usually the bigger one: how much of your PPO dependence is actually necessary? When one in five working-age adults has no benefits at all and financing approval rates are running near 90%, the case for accepting deep contract write-offs gets weaker every year. Our PPO-exit calculator lets you model what happens to your collections if you drop your worst-reimbursing plan and backfill with financed, fee-for-service production at your full fee. Plug in your plan mix, your write-off percentages, and your case values, and run your own numbers.